S. 150 · 118th Congress

Affordable Prescriptions for Patients Act of 2023

Introduced on Jan 30, 2023 by John Cornyn (R-TX). 8 cosponsors, 4 of them from another party. Latest action (Jul 15, 2024): Held at the desk.

Stage
Passed one chamber
Introduced
Jan 30, 2023
Cosponsors
8
4 from the other party
Policy area
Health
Open in the Congress explorerCongress.govAlert me

Progress

The furthest stage the measure reached. Simple and concurrent resolutions do not go to the President.

  1. Introduced
  2. Reported by committee
  3. Passed one chamber
  4. 4Passed both chambers
  5. 5Sent to the President
  6. 6Became law

Official title

A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes.

Subjects

  • Administrative remedies
  • Civil actions and liability
  • Competition and antitrust
  • Consumer affairs
  • Drug safety, medical device, and laboratory regulation
  • Federal Trade Commission (FTC)
  • Health care costs and insurance
  • Inflation and prices
  • Intellectual property
  • Judicial review and appeals
  • Manufacturing
  • Prescription drugs

Summary

The Congressional Research Service has not summarized this measure yet.

Sponsor and cosponsors

Cosponsors by party as of the day they signed on. Original cosponsors signed on the day of introduction.

John CornynR-TXSponsor

Democrats · 4

Republicans · 4

Roll calls

Recorded votes on the measure. Most measures move by voice vote or unanimous consent, which record no individual positions.

No recorded roll call on this measure: it moved by voice vote or unanimous consent, or has not reached the floor.

History

Every action as published, oldest first. Roll calls link to how each member voted.

  1. Jan 30, 2023Introduced in Senate
  2. Jan 30, 2023 · SenateRead twice and referred to the Committee on the Judiciary.
  3. Feb 9, 2023 · SenateCommittee on the Judiciary. Ordered to be reported without amendment favorably.
  4. Mar 1, 2023Committee on the Judiciary. Reported by Senator Durbin without amendment. Without written report.
  5. Mar 1, 2023 · SenateCommittee on the Judiciary. Reported by Senator Durbin without amendment. Without written report.
  6. Mar 1, 2023 · SenatePlaced on Senate Legislative Calendar under General Orders. Calendar No. 22.
  7. Jul 11, 2024 · SenateMeasure laid before Senate by unanimous consent. (consideration: CR S4537-4538)
  8. Jul 11, 2024Passed/agreed to in Senate: Passed Senate with an amendment by Unanimous Consent.
  9. Jul 11, 2024 · SenatePassed Senate with an amendment by Unanimous Consent. (text of amendment in the nature of a substitute: CR S4537-4538)
  10. Jul 12, 2024 · SenateMessage on Senate action sent to the House.
  11. Jul 15, 2024 · HouseReceived in the House.
  12. Jul 15, 2024 · HouseHeld at the desk.

Committees

Committees and subcommittees the measure was referred to.

Agencies in its committees' jurisdiction

Analisa's mapping of committee jurisdiction to federal agencies; the bill may touch others, or none of these.

Who lobbied on it

Organizations whose lobbying reports (LD-2) name this measure. Spending is what they reported for those quarters on all issues, not on this measure alone.

  1. PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA15 reports
    $37.4M reported (all issues)
  2. NOVO NORDISK INC.11 reports
    $16.6M reported (all issues)
  3. AMGEN INC.10 reports
    $15.2M reported (all issues)Federal contractor: AMGEN INC.AI match · 99%
  4. GUIDEWELL MUTUAL HOLDING CORPORATION9 reports
    $60K reported (all issues)
  5. ASSOCIATION FOR ACCESSIBLE MEDICINES8 reports
    $1.9M reported (all issues)
  6. Blue Cross and Blue Shield of Florida, Inc.8 reports
    $1.5M reported (all issues)
  7. Pharmaceutical Care Management Association (PCMA)8 reports
    $490K reported (all issues)
  8. BCBSM, Inc.7 reports
    $208.5K reported (all issues)
  9. PFIZER INC.7 reports
    $2.7M reported (all issues)Federal contractor: PFIZER INCAI match · 100%
  10. AARP6 reports
    $25.1M reported (all issues)
  11. Blue Cross and Blue Shield Association6 reports
    $10M reported (all issues)
  12. Chamber of Commerce of the U.S.A.6 reports
    $112.9M reported (all issues)
  13. ELI LILLY AND COMPANY6 reports
    Federal contractor: ELI LILLY AND COMPANY$286.4K in contracts, FY2026AI match · 100%
  14. TEVA PHARMACEUTICALS USA, INC.6 reports
    $2.5M reported (all issues)Federal contractor: TEVA PHARMACEUTICALS USA, INC.$25.9M in contracts, FY2026AI match · 100%
  15. AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP)5 reports
    $14.2M reported (all issues)
  16. AMERICAN INTELLECTUAL PROPERTY LAW ASSOCIATION (AIPLA)5 reports
    $10K reported (all issues)
  17. Amgen USA, Inc.5 reports
    $300K reported (all issues)Federal contractor: AMGEN USA INC$126M in contracts, FY2026AI match · 100%
  18. BIOTECHNOLOGY INNOVATION ORGANIZATION5 reports
    $8.9M reported (all issues)
  19. BLUE CROSS BLUE SHIELD OF MICHIGAN5 reports
    $1.3M reported (all issues)
  20. CAMBIA HEALTH SOLUTIONS INC.5 reports
    $3.2M reported (all issues)
  21. CONSUMER HEALTHCARE PRODUCTS ASSOCIATION5 reports
    $864.8K reported (all issues)
  22. Campaign for Sustainable Drug Pricing (CSRxP)5 reports
    $120K reported (all issues)
  23. Families USA Foundation, Inc.5 reports
    $76K reported (all issues)
  24. Fresenius Kabi USA LLC5 reports
    Federal contractor: FRESENIUS KABI USA, LLCAI match · 100%
  25. GENENTECH INC.5 reports
    Federal contractor: GENENTECH USA, INC$939.6K in contracts, FY2026AI match · 100%
  26. GSK (fka GLAXOSMITHKLINE INC.)5 reports
    $6.3M reported (all issues)
  27. JOHNSON & JOHNSON SERVICES, INC.5 reports
    $8.9M reported (all issues)
  28. MERCK & CO., INC.5 reports
    $11.1M reported (all issues)Federal contractor: MERCK SHARP & DOHME LLC$445.3K in contracts, FY2026AI match · 100%
  29. NATIONAL MULTIPLE SCLEROSIS SOCIETY5 reports
    $319.3K reported (all issues)
  30. Sanofi U.S. Services, Inc.5 reports
    $300K reported (all issues)
  31. The Campaign for Sustainable Rx Pricing5 reports
    $280K reported (all issues)
  32. Travere Therapeutics5 reports
    $635K reported (all issues)Federal contractor: TRAVERE THERAPEUTICS, INC.$323.9K in contracts, FY2026AI match · 100%
  33. VIATRIS INC.5 reports
  34. BLUE CROSS AND BLUE SHIELD OF KANSAS, INC.4 reports
    $45K reported (all issues)
  35. BLUECROSS BLUESHIELD OF TENNESSEE4 reports
    $1.1M reported (all issues)
  36. PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION4 reports
    $17.8M reported (all issues)
  37. Public Citizen4 reports
    $272.8K reported (all issues)
  38. SANOFI US SERVICES INC4 reports
    $5.7M reported (all issues)
  39. NOVARTIS CORPORATION3 reports
    $5.3M reported (all issues)Federal contractor: NOVARTIS PHARMACEUTICALS CORPORATION$36.2M in contracts, FY2026AI match · 100%
  40. The Cigna Group and subsidiaries (Formerly Cigna Corporation3 reports
    $5.3M reported (all issues)

Reports filed in 2023, 2024, 2025, 2026.

Sources and method

Every figure on this page traces to these records.

  • Bill status: bills and resolutions, sponsors, actions, subjects and CRS summaries (U.S. Government Publishing Office (GovInfo), from Congress.gov (Library of Congress))GovInfo Bill Status bulk data (Congress.gov; summaries by the Congressional Research Service) · data current to Oct 6, 2026 · loaded Oct 6, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Members of Congress, their terms, committees and identifiers (The @unitedstates project (from the Biographical Directory of the U.S. Congress, the House and the Senate))unitedstates/congress-legislators: legislators, committees and current committee membership · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: CC0 1.0 (public domain dedication)
  • House roll-call votes (Office of the Clerk, U.S. House of Representatives)Office of the Clerk, U.S. House of Representatives, roll-call vote records · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Senate roll-call votes and DW-NOMINATE scores (Voteview (UCLA Department of Political Science))Lewis, Jeffrey B., Keith Poole, Howard Rosenthal, Adam Boche, Aaron Rudkin, and Luke Sonnet (2026). Voteview: Congressional Roll-Call Votes Database. https://voteview.com/ · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Free to use with the required citation
  • Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives)Clerk of the House, Lobbying Disclosure Act filings (organizations only; lobbyists' names are not loaded) · data current to Oct 6, 2026 · loaded Oct 6, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Positions are shown only where a roll call recorded them; voice votes and unanimous consent record none.
  • Money and votes are shown side by side; neither explains the other.